S/MAR sequence confers long-term mitotic stability on non-integrating lentiviral vector episomes without selection

Nucleic Acids Research

Volumn 42, Issue 7, 2014, Pages

  Verghese, Santhosh Chakkaramakkil ^a   Goloviznina, Natalya A ^a   Skinner, Amy M ^a   Lipps, Hans J ^b   Kurre, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CLONE; CELL CYCLE PARAMETERS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CHIMERA; CONTROLLED STUDY; DNA REPLICATION ORIGIN; EMBRYO; EPISOME; GENE EXPRESSION; GENE STRUCTURE; GENETIC SELECTION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LONG TERMINAL REPEAT; MITOTIC STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCAFFOLD MATRIX ASSOCIATED REGION SEQUENCE; SINGLE CELL ANALYSIS; TRANSGENE;

ANIMALS; CELL LINE; GENE EXPRESSION; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON-BETA; LENTIVIRUS; MATRIX ATTACHMENT REGIONS; MICE; MITOSIS; PLASMIDS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84898989692     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku082     Document Type: Article

References (52)

1. Matrai, J., Chuah, M.K. and VandenDriessche, T. (2010) Recent advances in lentiviral vector development and applications. Mol ther., 18, 477-490.
2. Modlich, U., Navarro, S., Zychlinski, D., Maetzig, T., Knoess, S., Brugman, M.H., Schambach, A., Charrier, S., Galy, A., Thrasher, A.J. et al. (2009) Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol ther., 17, 1919-1928.
3. Kustikova, O.S., Schiedlmeier, B., Brugman, M.H., Stahlhut, M., Bartels, S., Li, Z. and Baum, C. (2009) Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis. Mol ther., 17, 1537-1547.
4. Cockrell, A.S. and Kafri, T. (2007) Gene delivery by lentivirus vectors. Mol. Biotechnol., 36, 184-204. (Pubitemid 350135911)
5. Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J. and Serguera, C. (2006) Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl Acad. Sci. USA, 103, 17684-17689. (Pubitemid 44852220)
6. Yanez-Munoz, R.J., Balaggan, K.S., MacNeil, A., Howe, S.J., Schmidt, M., Smith, A.J., Buch, P., MacLaren, R.E., Anderson, P.N., Barker, S.E. et al. (2006) Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med., 12, 348-353. (Pubitemid 43355085)
7. Philpott, N.J. and Thrasher, A.J. (2007) Use of nonintegrating lentiviral vectors for gene therapy. Hum. Gene Ther., 18, 483-489. (Pubitemid 47036043)
8. Apolonia, L., Waddington, S.N., Fernandes, C., Ward, N.J., Bouma, G., Blundell, M.P., Thrasher, A.J., Collins, M.K. and Philpott, N.J. (2007) Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol ther., 15, 1947-1954. (Pubitemid 350011734)
9. Sarkis, C., Philippe, S., Mallet, J. and Serguera, C. (2008) Non-integrating lentiviral vectors. Curr. Gene Ther., 8, 430-437.
10. Kantor, B., Bayer, M., Ma, H., Samulski, J., Li, C., McCown, T. and Kafri, T. (2011) Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector. Mol ther., 19, 547-556.
11. Pierson, T.C., Kieffer, T.L., Ruff, C.T., Buck, C., Gange, S.J. and Siliciano, R.F. (2002) Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J. Virol., 76, 4138-4144. (Pubitemid 34250581)
12. Flynn, R.P., Zacharias, J., Zhou, X., Cannon, M.L. and Philpott, N.J. (2011) Non-integrating lentiviral vectors for specific killing of Epstein-Barr virus nuclear antigen 1-positive B cell lymphoma cells. J. Gene Med., 13, 487-496.
13. Vargas, J. Jr, Gusella, G.L., Najfeld, V., Klotman, M.E. and Cara, A. (2004) Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum. Gene Ther., 15, 361-372. (Pubitemid 38469778)
14. Vargas, J. Jr, Klotman, M.E. and Cara, A. (2008) Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy. Antiviral Res, 80, 288-294.
15. Chernov, I.P., Akopov, S.B. and Nikolaev, L.G. (2004) Structure and function of nuclear matrix associated regions (S/MARs). Russ. Bioorg. Chem., 30, 3-14.
16. Hagedorn, C., Wong, S.P., Harbottle, R. and Lipps, H.J. (2011) Scaffold/matrix attached region-based nonviral episomal vectors. Hum. Gene Ther., 22, 915-923.
17. Mirkovitch, J., Mirault, M.E. and Laemmli, U.K. (1984) Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell, 39, 223-232. (Pubitemid 15218240)
18. Stehle, I.M., Postberg, J., Rupprecht, S., Cremer, T., Jackson, D.A. and Lipps, H.J. (2007) Establishment and mitotic stability of an extra-chromosomal mammalian replicon. BMC Cell Biol., 8, 33.
19. Schaarschmidt, D., Baltin, J., Stehle, I.M., Lipps, H.J. and Knippers, R. (2004) An episomal mammalian replicon: sequence-independent binding of the origin recognition complex. EMBO J., 23, 191-201. (Pubitemid 38165759)
20. Baiker, A., Maercker, C., Piechaczek, C., Schmidt, S.B., Bode, J., Benham, C. and Lipps, H.J. (2000) Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nat. Cell Biol., 2, 182-184.
21. Agarwal, M., Austin, T.W., Morel, F., Chen, J., Bohnlein, E. and Plavec, I. (1998) Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J. Virol., 72, 3720-3728. (Pubitemid 28188670)
22. Broll, S., Oumard, A., Hahn, K., Schambach, A. and Bode, J. (2010) Minicircle performance depending on S/MAR-nuclear matrix interactions. J. Mol. Biol., 395, 950-965.
23. Buceta, M., Galbete, J.L., Kostic, C., Arsenijevic, Y. and Mermod, N. (2011) Use of human MAR elements to improve retroviral vector production. Gene Ther., 18, 7-13.
24. Grandchamp, N., Henriot, D., Philippe, S., Amar, L., Ursulet, S., Serguera, C., Mallet, J. and Sarkis, C. (2011) Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors. Genet. Vaccines Ther., 9, 1.
25. Jenke, A.C., Stehle, I.M., Herrmann, F., Eisenberger, T., Baiker, A., Bode, J., Fackelmayer, F.O. and Lipps, H.J. (2004) Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc. Natl Acad. Sci. USA, 101, 11322-11327. (Pubitemid 39038345)
26. Piechaczek, C., Fetzer, C., Baiker, A., Bode, J. and Lipps, H.J. (1999) A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res., 27, 426-428. (Pubitemid 29210004)
27. Papapetrou, E.P., Ziros, P.G., Micheva, I.D., Zoumbos, N.C. and Athanassiadou, A. (2006) Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element. Gene Ther., 13, 40-51. (Pubitemid 41823850)
28. Voigtlander, R., Haase, R., Muck-Hausl, M., Zhang, W., Boehme, P., Lipps, H.J., Schulz, E., Baiker, A. and Ehrhardt, A. (2013) A novel adenoviral hybrid-vector system carrying a plasmid replicon for safe and efficient cell and gene therapeutic applications. Mol ther. Nucleic Acids, 2, e83.
29. Wanisch, K. and Yanez-Munoz, R.J. (2009) Integration-deficient lentiviral vectors: a slow coming of age. Mol ther., 17, 1316-1332.
30. Kurre, P., Anandakumar, P. and Kiem, H.P. (2006) Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells. Gene Ther., 13, 369-373. (Pubitemid 43223106)
31. Pan, Y.W., Scarlett, J.M., Luoh, T.T. and Kurre, P. (2007) Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo. J. Virol., 81, 639-649. (Pubitemid 46067891)
32. Bell, P., Montaner, L.J. and Maul, G.G. (2001) Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. J. Virol., 75, 7683-7691. (Pubitemid 32738026)
33. Klein, R., Ruttkowski, B., Knapp, E., Salmons, B., Gunzburg, W.H. and Hohenadl, C. (2006) WPRE-mediated enhancement of gene expression is promoter and cell line specific. Gene, 372, 153-161.
34. Bayer, M., Kantor, B., Cockrell, A., Ma, H., Zeithaml, B., Li, X., McCown, T. and Kafri, T. (2008) A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector. Mol ther., 16, 1968-1976.
35. Butler, S.L., Hansen, M.S. and Bushman, F.D. (2001) A quantitative assay for HIV DNA integration in vivo. Nat. Med., 7, 631-634. (Pubitemid 32448333)
36. Banasik, M.B. and McCray, P.B. Jr (2010) Integrase-defective lentiviral vectors: progress and applications. Gene Ther., 17, 150-157.
37. Tessadori, F., Zeng, K., Manders, E., Riool, M., Jackson, D. and van Driel, R. (2010) Stable S/MAR-based episomal vectors are regulated at the chromatin level. Chromosome Res., 18, 757-775.
38. Leavitt, A.D., Robles, G., Alesandro, N. and Varmus, H.E. (1996) Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol., 70, 721-728. (Pubitemid 26028986)
39. Nightingale, S.J., Hollis, R.P., Pepper, K.A., Petersen, D., Yu, X.J., Yang, C., Bahner, I. and Kohn, D.B. (2006) Transient gene expression by nonintegrating lentiviral vectors. Mol ther., 13, 1121-1132. (Pubitemid 43796157)
40. Terskikh, A.V., Ershler, M.A., Drize, N.J., Nifontova, I.N. and Chertkov, J.L. (2005) Long-term persistence of a nonintegrated lentiviral vector in mouse hematopoietic stem cells. Exp. Hematol., 33, 873-882. (Pubitemid 40982653)
41. Kurre, P., Morris, J., Thomasson, B., Kohn, D.B. and Kiem, H.P. (2003) Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells. Blood, 102, 3117-3119. (Pubitemid 37314746)
42. Sgourou, A., Routledge, S., Spathas, D., Athanassiadou, A. and Antoniou, M.N. (2009) Physiological levels of HBB transgene expression from S/MAR element-based replicating episomal vectors. J. Biotechnol., 143, 85-94.
43. Argyros, O., Wong, S.P., Fedonidis, C., Tolmachov, O., Waddington, S.N., Howe, S.J., Niceta, M., Coutelle, C. and Harbottle, R.P. (2011) Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver. J. Mol. Med. (Berl), 89, 515-529.
44. Jackson, D.A., Juranek, S. and Lipps, H.J. (2006) Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol ther., 14, 613-626. (Pubitemid 44480753)
45. Leight, E.R. and Sugden, B. (2001) Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol. Cell Biol., 21, 4149-4161. (Pubitemid 32565297)
46. Ramezani, A., Hawley, T.S. and Hawley, R.G. (2003) Performanceand safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood, 101, 4717-4724. (Pubitemid 36857727)
47. Hagedorn, C., Baiker, A., Postberg, J., Ehrhardt, A. and Lipps, H.J. (2012) Handling S/MAR vectors. Cold Spring Harb. Protoc., 2012, 657-663.
48. Wong, S.P., Argyros, O., Coutelle, C. and Harbottle, R.P. (2011) Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage. Gene Ther., 18, 82-87.
49. Rupprecht, S., Hagedorn, C., Seruggia, D., Magnusson, T., Wagner, E., Ogris, M. and Lipps, H.J. (2010) Controlled removal of a nonviral episomal vector from transfected cells. Gene, 466, 36-42.
50. Kurre, P., Anandakumar, P., Harkey, M.A., Thomasson, B. and Kiem, H.P. (2004) Efficient marking of murine long-term repopulating stem cells targeting unseparated marrow cells at low lentiviral vector particle concentration. Mol ther., 9, 914-922. (Pubitemid 38878137)
51. Noll, M., Bateman, R.L., D'Andrea, A.D. and Grompe, M. (2001) Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C. Mol ther., 3, 14-23. (Pubitemid 32509800)
52. Zielske, S.P., Reese, J.S., Lingas, K.T., Donze, J.R. and Gerson, S.L. (2003) In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning. J. Clin. Invest., 112, 1561-1570. (Pubitemid 38056282)